Lupin’s Deal For Soft-Mist Inhalation Tech Gives Access To Spiriva Respimat Platform
Partners With Biomm For Neulasta Biosimilar In Brazil
With global rights to TTP's soft-mist inhalation platform, Lupin gets access to the drug delivery system used by Boehringer Ingelheim for Spiriva Respimat and it will be interesting to watch pricing as Lupin leverages the aerosolization technology across respiratory products. Meanwhile, the company has entered a partnership with Biomm for marketing its Neulasta biosimilar in Brazil.
